PURPOSE: Both (131)I- and (123)I-labeled meta-iodobenzylguanidine (MIBG) have been widely used in the clinic for targeted imaging of the norepinephrine transporter (NET). The human NET (hNET) gene has been imaged successfully with (124)I-MIBG positron emission tomography (PET) at time points of >24 h post-injection (p.i.). (18)F-labeled MIBG analogs may be ideal to image hNET expression at time points of <8 h p.i. We developed improved methods for the synthesis of known MIBG analogs, [(18)F]MFBG and [(18)F]PFBG and evaluated them in hNET reporter gene-transduced C6 rat glioma cells and xenografts. METHODS: [(18)F]MFBG and [(18)F]PFBG were synthesized manually using a three-step synthetic scheme. Wild-type and hNET reporter gene-transduced C6 rat glioma cells and xenografts were used to comparatively evaluate the (18)F-labeled analogs with [(123)I]/[(124)I]MIBG. RESULTS: The fluorination efficacy on benzonitrile was predominantly determined by the position of the trimethylammonium group. The para-isomer afforded higher yields (75 ± 7%) than meta-isomer (21 ± 5%). The reaction of [(18)F]fluorobenzylamine with 1H-pyrazole-1-carboximidamide was more efficient than with 2-methyl-2-thiopseudourea. The overall radiochemical yields (decay-corrected) were 11 ± 2% (n = 12) for [(18)F]MFBG and 41 ± 12% (n = 5) for [(18)F]PFBG, respectively. The specific uptakes of [(18)F]MFBG and [(18)F]PFBG were similar in C6-hNET cells, but 4-fold less than that of [(123)I]/[(124)I]MIBG. However, in vivo [(18)F]MFBG accumulation in C6-hNET tumors was 1.6-fold higher than that of [(18)F]PFBG at 1 h p.i., whereas their uptakes were similar at 4 h. Despite [(18)F]MFBG having a 2.8-fold lower affinity to hNET and approximately 4-fold lower cell uptake in vitro compared to [(123)I]/[(124)I]MIBG, PET imaging demonstrated that [(18)F]MFBG was able to visualize C6-hNET xenografts better than [(124)I]MIBG. Biodistribution studies showed [(18)F]MFBG and (123)I-MIBG had a similar tumor accumulation, which was lower than that of no-carrier-added [(124)I]MIBG, but [(18)F]MFBG showed a significantly more rapid body clearance and lower uptake in most non-targeting organs. CONCLUSION: [(18)F]MFBG and [(18)F]PFBG were synthesized in reasonable radiochemical yields under milder conditions. [(18)F]MFBG is a better PET ligand to image hNET expression in vivo at 1-4 h p.i. than both [(18)F]PFBG and [(123)I]/[(124)I]MIBG.
PURPOSE: Both (131)I- and (123)I-labeled meta-iodobenzylguanidine (MIBG) have been widely used in the clinic for targeted imaging of the norepinephrine transporter (NET). The humanNET (hNET) gene has been imaged successfully with (124)I-MIBG positron emission tomography (PET) at time points of >24 h post-injection (p.i.). (18)F-labeled MIBG analogs may be ideal to image hNET expression at time points of <8 h p.i. We developed improved methods for the synthesis of known MIBG analogs, [(18)F]MFBG and [(18)F]PFBG and evaluated them in hNET reporter gene-transduced C6 ratglioma cells and xenografts. METHODS:[(18)F]MFBG and [(18)F]PFBG were synthesized manually using a three-step synthetic scheme. Wild-type and hNET reporter gene-transduced C6 ratglioma cells and xenografts were used to comparatively evaluate the (18)F-labeled analogs with [(123)I]/[(124)I]MIBG. RESULTS: The fluorination efficacy on benzonitrile was predominantly determined by the position of the trimethylammonium group. The para-isomer afforded higher yields (75 ± 7%) than meta-isomer (21 ± 5%). The reaction of [(18)F]fluorobenzylamine with 1H-pyrazole-1-carboximidamide was more efficient than with 2-methyl-2-thiopseudourea. The overall radiochemical yields (decay-corrected) were 11 ± 2% (n = 12) for [(18)F]MFBG and 41 ± 12% (n = 5) for [(18)F]PFBG, respectively. The specific uptakes of [(18)F]MFBG and [(18)F]PFBG were similar in C6-hNET cells, but 4-fold less than that of [(123)I]/[(124)I]MIBG. However, in vivo [(18)F]MFBG accumulation in C6-hNET tumors was 1.6-fold higher than that of [(18)F]PFBG at 1 h p.i., whereas their uptakes were similar at 4 h. Despite [(18)F]MFBG having a 2.8-fold lower affinity to hNET and approximately 4-fold lower cell uptake in vitro compared to [(123)I]/[(124)I]MIBG, PET imaging demonstrated that [(18)F]MFBG was able to visualize C6-hNET xenografts better than [(124)I]MIBG. Biodistribution studies showed [(18)F]MFBG and (123)I-MIBG had a similar tumor accumulation, which was lower than that of no-carrier-added [(124)I]MIBG, but [(18)F]MFBG showed a significantly more rapid body clearance and lower uptake in most non-targeting organs. CONCLUSION:[(18)F]MFBG and [(18)F]PFBG were synthesized in reasonable radiochemical yields under milder conditions. [(18)F]MFBG is a better PET ligand to image hNET expression in vivo at 1-4 h p.i. than both [(18)F]PFBG and [(123)I]/[(124)I]MIBG.
Authors: Maxim A Moroz; Inna Serganova; Pat Zanzonico; Ludmila Ageyeva; Tatiana Beresten; Ekaterina Dyomina; Eva Burnazi; Ronald D Finn; Michael Doubrovin; Ronald G Blasberg Journal: J Nucl Med Date: 2007-05 Impact factor: 10.057
Authors: Martina Anton; Bettina Wagner; Roland Haubner; Claudia Bodenstein; Bryan E Essien; Heinz Bönisch; Markus Schwaiger; Bernd Gansbacher; Wolfgang A Weber Journal: J Gene Med Date: 2004-01 Impact factor: 4.565
Authors: Bao Hu; Amy L Vāvere; Kiel D Neumann; Barry L Shulkin; Stephen G DiMagno; Scott E Snyder Journal: ACS Chem Neurosci Date: 2015-09-11 Impact factor: 4.418
Authors: Neeta Pandit-Taskar; Pat Zanzonico; Kevin D Staton; Jorge A Carrasquillo; Diane Reidy-Lagunes; Serge Lyashchenko; Eva Burnazi; Hanwen Zhang; Jason S Lewis; Ronald Blasberg; Steven M Larson; Wolfgang A Weber; Shakeel Modak Journal: J Nucl Med Date: 2017-07-13 Impact factor: 10.057
Authors: Yong-Woon Jung; Keun Sam Jang; Guie Gu; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; David M Raffel Journal: ACS Chem Neurosci Date: 2017-03-27 Impact factor: 4.418
Authors: Maxim A Moroz; Hanwen Zhang; Jason Lee; Ekaterina Moroz; Juan Zurita; Larissa Shenker; Inna Serganova; Ronald Blasberg; Vladimir Ponomarev Journal: J Nucl Med Date: 2015-05-29 Impact factor: 10.057
Authors: Hanwen Zhang; Ruimin Huang; Nai-Kong V Cheung; Hongfen Guo; Pat B Zanzonico; Howard T Thaler; Jason S Lewis; Ronald G Blasberg Journal: Clin Cancer Res Date: 2014-02-26 Impact factor: 12.531
Authors: Rachael W Sirianni; Ming-Qiang Zheng; Toral R Patel; Thomas Shafbauer; Jiangbing Zhou; W Mark Saltzman; Richard E Carson; Yiyun Huang Journal: Bioconjug Chem Date: 2014-12-01 Impact factor: 4.774